chr17-64557641-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2
The NM_022739.4(SMURF2):āc.1398A>Gā(p.Thr466=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000113 in 1,610,336 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: š 0.00041 ( 0 hom., cov: 32)
Exomes š: 0.000082 ( 1 hom. )
Consequence
SMURF2
NM_022739.4 synonymous
NM_022739.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.35
Genes affected
SMURF2 (HGNC:16809): (SMAD specific E3 ubiquitin protein ligase 2) Enables SMAD binding activity; identical protein binding activity; and ubiquitin-protein transferase activity. Involved in negative regulation of transforming growth factor beta receptor signaling pathway; positive regulation of trophoblast cell migration; and ubiquitin-dependent SMAD protein catabolic process. Located in nuclear speck. Part of ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 17-64557641-T-C is Benign according to our data. Variant chr17-64557641-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 3040421.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-4.35 with no splicing effect.
BS2
High AC in GnomAd4 at 63 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMURF2 | NM_022739.4 | c.1398A>G | p.Thr466= | synonymous_variant | 13/19 | ENST00000262435.14 | NP_073576.1 | |
SMURF2 | XM_047436546.1 | c.1404A>G | p.Thr468= | synonymous_variant | 13/19 | XP_047292502.1 | ||
SMURF2 | XM_005257585.4 | c.1359A>G | p.Thr453= | synonymous_variant | 12/18 | XP_005257642.1 | ||
SMURF2 | XR_007065425.1 | n.4456A>G | non_coding_transcript_exon_variant | 13/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMURF2 | ENST00000262435.14 | c.1398A>G | p.Thr466= | synonymous_variant | 13/19 | 1 | NM_022739.4 | ENSP00000262435 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152192Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
58
AN:
152192
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000164 AC: 41AN: 250182Hom.: 0 AF XY: 0.000163 AC XY: 22AN XY: 135234
GnomAD3 exomes
AF:
AC:
41
AN:
250182
Hom.:
AF XY:
AC XY:
22
AN XY:
135234
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000816 AC: 119AN: 1458026Hom.: 1 Cov.: 28 AF XY: 0.0000868 AC XY: 63AN XY: 725502
GnomAD4 exome
AF:
AC:
119
AN:
1458026
Hom.:
Cov.:
28
AF XY:
AC XY:
63
AN XY:
725502
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000414 AC: 63AN: 152310Hom.: 0 Cov.: 32 AF XY: 0.000470 AC XY: 35AN XY: 74482
GnomAD4 genome
AF:
AC:
63
AN:
152310
Hom.:
Cov.:
32
AF XY:
AC XY:
35
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SMURF2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 10, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at